PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BSX vs. SNN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BSX and SNN is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

BSX vs. SNN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and Smith & Nephew plc (SNN). The values are adjusted to include any dividend payments, if applicable.

400.00%450.00%500.00%550.00%600.00%650.00%700.00%750.00%JulyAugustSeptemberOctoberNovemberDecember
700.27%
453.48%
BSX
SNN

Key characteristics

Sharpe Ratio

BSX:

3.48

SNN:

-0.13

Sortino Ratio

BSX:

4.70

SNN:

-0.00

Omega Ratio

BSX:

1.64

SNN:

1.00

Calmar Ratio

BSX:

8.18

SNN:

-0.07

Martin Ratio

BSX:

34.81

SNN:

-0.35

Ulcer Index

BSX:

1.68%

SNN:

10.09%

Daily Std Dev

BSX:

16.85%

SNN:

26.12%

Max Drawdown

BSX:

-89.15%

SNN:

-55.20%

Current Drawdown

BSX:

-3.79%

SNN:

-45.31%

Fundamentals

Market Cap

BSX:

$133.28B

SNN:

$11.09B

EPS

BSX:

$1.21

SNN:

$0.70

PE Ratio

BSX:

74.74

SNN:

36.34

PEG Ratio

BSX:

1.64

SNN:

0.42

Total Revenue (TTM)

BSX:

$15.91B

SNN:

$5.62B

Gross Profit (TTM)

BSX:

$10.71B

SNN:

$3.88B

EBITDA (TTM)

BSX:

$3.73B

SNN:

$1.07B

Returns By Period

In the year-to-date period, BSX achieves a 52.27% return, which is significantly higher than SNN's -6.11% return. Over the past 10 years, BSX has outperformed SNN with an annualized return of 20.99%, while SNN has yielded a comparatively lower -1.10% annualized return.


BSX

YTD

52.27%

1M

-2.68%

6M

15.36%

1Y

57.70%

5Y*

14.22%

10Y*

20.99%

SNN

YTD

-6.11%

1M

-2.55%

6M

-0.04%

1Y

-4.40%

5Y*

-10.04%

10Y*

-1.10%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BSX vs. SNN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Smith & Nephew plc (SNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BSX, currently valued at 3.48, compared to the broader market-4.00-2.000.002.003.48-0.13
The chart of Sortino ratio for BSX, currently valued at 4.70, compared to the broader market-4.00-2.000.002.004.004.70-0.00
The chart of Omega ratio for BSX, currently valued at 1.64, compared to the broader market0.501.001.502.001.641.00
The chart of Calmar ratio for BSX, currently valued at 8.18, compared to the broader market0.002.004.006.008.18-0.07
The chart of Martin ratio for BSX, currently valued at 34.80, compared to the broader market0.0010.0020.0034.81-0.35
BSX
SNN

The current BSX Sharpe Ratio is 3.48, which is higher than the SNN Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of BSX and SNN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00JulyAugustSeptemberOctoberNovemberDecember
3.48
-0.13
BSX
SNN

Dividends

BSX vs. SNN - Dividend Comparison

BSX has not paid dividends to shareholders, while SNN's dividend yield for the trailing twelve months is around 3.01%.


TTM20232022202120202019201820172016201520142013
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SNN
Smith & Nephew plc
3.01%2.75%2.79%2.17%1.78%1.51%1.96%1.76%2.08%1.71%1.52%1.85%

Drawdowns

BSX vs. SNN - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than SNN's maximum drawdown of -55.20%. Use the drawdown chart below to compare losses from any high point for BSX and SNN. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-3.79%
-45.31%
BSX
SNN

Volatility

BSX vs. SNN - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 4.59% compared to Smith & Nephew plc (SNN) at 4.37%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than SNN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%JulyAugustSeptemberOctoberNovemberDecember
4.59%
4.37%
BSX
SNN

Financials

BSX vs. SNN - Financials Comparison

This section allows you to compare key financial metrics between Boston Scientific Corporation and Smith & Nephew plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab